RESULTS

1) Epidemiological and clinical studies
The epidemic occurred first in Room C and extended to Room D. Two peaks were found and the incubation period was estimated to be about 15 days. As shown in Fig. 1 , 18 infants had clinical mumps and 15 subclinical . The attack rate examined by HI tests was 33/47 (70%). In Room A only one infant was infected and he was subclinical. It was characteristic that most infants in Room B remained to be subclinical. The clinical features were shown in Table  1 . Parotid swelling was the most common sign among them . Of the total 18 cases with clinical mumps 17 (94%) had parotid swelling . One patient (Case 35) had only fever without any other clinical manifestations . Two patients (Cases 31 and 47) had vomiting and convulsion and were suspected to have central nervous system involvement; but lumbar puncture was not performed. Mean duration of parotid swelling and fever were 6.2 and 3.8 days, respectively. The youngest infant with clinical manifestation was an 11-month-old female (Case 17) who had fever and parotid swelling.
2) Serological studies Fig. 2 shows the development of mumps HI antibody titers after the day of onset of illness. The antibodies became detectable in the sera obtained by the end of the first week after the onset. At 1 month after the onset most infants had HI antibody titers of 1: 64 or greater. By the end of 2 months after the onset all the infants which were examined by HI tests had antibody titers of 1: 32 or greater. A 14-month-old male (Case 27) with parotid swelling showed no antibody response, and displayed hypogammaglobulinemia. In Room D 8 infants had HI antibody titers less than 1: 8 and 2 had the titer of 1: 8 at the pre-epidemic stage. Table 2 shows HI and FA titers in the sera treated with 2-mercaptoethanol (2-ME). As can be seen from Case 35, a 16-month-old female, who had only fever as clinical sign, HI antibody titer was 1: 512 or greater in the serum treated with 2-ME and also in the control serum, therefore IgM antibody seemed to already disappear in the serum obtained 25 days after the onset. According to FA test the fluorescence of IgM antibodies which was found in the control serum disappeared from the serum treated with 2-ME, and then IgM antibody was proved to remain in the serum obtained at the early stage of mumps infection.
4) Detection of maternal mumps antibodies in sera of the infants by the different methods
The antibody titers of the infants in Room A whose mean age (5.2 months) are younger than the infants in the other rooms are shown in Table 3 . Only one 
DISCUSSION
The majority of mumps is said to develop in an age group of 5 to 10 years and to be rare in infancy (Krugman and Ward 1968). Philip et al. (1959) reported that the attack rate of mumps infection among young children under 1 year of age were very low in the observation on a mumps epidemic in a "virgin" population on St. Lawrence Island in the Bering Sea. Even in our experience during this epidemic only 1 infant was attacked among the infants of Room A whose mean ages (5.2 months) were younger than the infants of other rooms. Infection with mumps virus usually develops after an incubation period of 16 to 18 days (Krugman and Ward 1968). Incubation period in this epidemic was about 15 days. Philip et al. (1959) found that in a population where virtually all members were suscepti ble 88% were infected during the epidemic. All the infants in Room D were susceptible and 80% among them were infected. Many of the infants in Room B had subclinical mumps as compared with those in Rooms C and D . This reason has been unknown, but transplacental maternal antibodies which were below the detectable range by HI tests or NT might play a role in this difference. The clinical features or mean duration of parotid swelling and fever were same as those of mumps seen elsewhere. The source of mumps infection was unknown in this epidemic. There was no staff with clinical mumps in the nursery.
HI antibodies became detectable earlier than the neutralizing antibodies (NA) . By the end of 2 months after onset the infants examined by HI tests had antibody titers of 1: 32 or greater.
Therefore HI antibody titer of 1: 32 or greater was considered to be a serologic evidence of a mumps infection.
NT titers reached a peak between 4 and 5 weeks and persisted high for a longer period.
These results were similar to the observations by Brown et al . (1970) .
No attempts have been made to use FA tests for assay of mumps antibodies until Cerini and Cabasso (1968) utilized first the method in the sera which were obtained from children inoculated with a live attenuated vaccine . Thereafter Brown et al. (1970) used the method to detect mumps antibodies in patients . In their reports the development and duration of mumps fluorescent antibodies follow ing the onset of illness were described in detail . The most prominent difference of the development and duration of IgG and IgM mumps fluorescent antibodies was that the former continued undiminished for over 2 months , while the latter disappeared by about 80 days after the onset. Brown et al . (1970) obtained the same results. As expected, FA tests were more specific than 2-ME treatment method to decide the type of immunoglobulin in the sera after the day of onset .
There are many factors giving influence on resistance to viral infections in infancy. The resistance to viral infections , such as mumps, is strong in infancy. Meyer et al. (1966) stated that the morbidity rate among family contacts with a negative history was 17% for children under 1 , but 64% for 2 to 4-year-old. The reasons remain still unknown. Florman and Karelitz (1953) advocated the reasons such as the frequency and severity of exposure to the viruses , the innate resistance of the tissues and the presence of circulating specific antibodies . The disappearance of maternal CF and HI antibodies against mumps virus from the sera of infants was shown to be rapid in their study . Therefore they said that it was difficult to put the rarity of mumps in young infants on placenta-passing mumps antibodies. They said also that one must look to other factors, for example the limited opportunity for exposure to infectious agents , to account for the rarity of mumps in infancy. Philip et al. (1959) reported a epidemic mumps in the St. Lawrence Island, where there was no history of epidemic mumps . Therefore during the epidemic maternal antibodies would not have been concerned. The occurrence of mumps in young infants was also very low during the epidemic. They suggested also that less intense exposure and, perhaps, greater inherent resistance were responsible for the lower morbidity observed among very young children. Yet we cannot neglect the influence of maternal antibodies on viral infections of infants.
Duration of maternal mumps antibodies in sera of infants differed accord ing to the methods or investigators. Buynak et al. (1968) said in their investiga tion of attenuated mumps virus vaccine that antibodies in 3 and 4-month-old infants were almost certainly of maternal origin. Hodes and Brunell (1970) reported that NA due to maternal origin was detectable in sera of 13 infants among 19 infants who were tested at 5 months of age. But none of 18 infants had detectable NA at 1 year of age. There were considerable variations at the rates of disappearance of maternal antibodies in individuals (Florman and Karelitz 1953). From our data (Table 3) it was suggested that maternal antibodies examined by FA tests would remain for about 7 or 9 months in sera of the infants. According to these reports it is difficult to put the rarity of mumps in young infants on only transplacental maternal antibodies.
In Room A the infants escaped from mumps infection had no HI and NA against mumps virus, but they all had IgG mumps fluorescent antibodies. Infants attacked in other rooms had no IgG fluorescent antibodies in the pre epidemic sera. From our data it was suggested that even the low titer of transplacental maternal antibodies which were not detectable by HI tests or NT but FA tests could protect the infants from a mumps infection. Many infants in Room B had subclinical mumps as compared with those in Rooms C and D. We suggested also that in these infants maternal antibodies would be responsible. Inactivated mumps virus vaccine caused a reduction in the incidence of mumps and also in the severity of the clinical manifestations among the vaccinated as compared to control groups (Habel 1951). Thus the maternal antibodies which pass the placenta would be undoubtedly one of the factors protecting a mumps infection.
According to the results of HI tests and NT, 3 infants (Cases 5, 7 and 9) were considered to be attacked in Room A. But from the results by FA tests it was clear that the detected antibodies of the 2 (Cases 5 and 7) would be of maternal origin. FA tests are good in deciding whether the antibody detected was the one being produced by the infection during the epidemic or was of maternal origin.
Recently 2 cases of parotitis by parainfluenza virus type 3 were reported (Zollar and Mufson 1970), and it is also said that the sera of mumps patients react with the parainfluenza virus of types 1, 2 and 3 (Chanock and Johnson 1964) . Therefore it is difficult to diagnose only by the serological methods whether paro titis is due to mumps virus or parainfluenza viruses. However, Brown et al. (1970) described that mumps infection was differentiated from parainfluenza virus infection when anti-IgM serum was employed in FA tests. IgM mumps fluorescent antibody was specifically detected in sera obtained from those who received a recent infec tion of mumps.
